| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213 [G. R. M.], and Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114 [R. K. J.]
The tumor interstitial pH and its modification play a significant role in cancer treatment. Current in vivo pH measurement techniques are invasive and/or provide poor spatial resolution. Therefore, there are no data on perivascular interstitial pH gradients in normal or tumor tissue. We have optically measured interstitial pH gradients with high resolution in normal and tumor (VX2 carcinoma) tissue in vivo by combining a fluorescence ratio imaging microscopy technique and the rabbit ear chamber preparation. The strengths of our approach include the ability to follow pH in the same location for several weeks and to relate these measurements to local blood flow and vascular architecture. Our results show: (a) tumor interstitial pH (6.75 units; N = 6 animals, n = 324 measurements) is significantly (P < 0.001) less than normal interstitial pH (7.23; N = 5, n = 274). This increased acidity in the tumor interstitium is in agreement with the previously reported data on this tumor; (b) with respect to pH spatial gradients in normal tissue, the interstitial pH decreased by approximately 0.32 pH units over a distance of 50 µm away from the blood vessel, while in tumor tissue, interstitial pH decreased by approximately 0.13 units over the same distance. Although the pH gradient near the vessel wall was steeper in normal tissue compared to tumor, the proton concentration gradient in normal tissue was less than that in the tumor. The approximate increase in proton concentration from 0 to 50 µm from the vessel was 4.5 x 10-8 M in normal versus 5.7 x 10-8 M in tumor tissue; (c) a simple one-dimensional diffusion-reaction model suggested that tumor tissue was producing protons at a rate 65–100% greater than normal tissue; (d) feasibility studies of temporal dynamics resulting from hyperglycemia (6 g/kg) or hypercapnia (10% CO2) led to significant (P < 0.05) interstitial pH reductions. During hyperglycemia, pH dropped by more than 0.2 pH units in about 90 min in tumor tissue but remained constant in normal tissue. Hypercapnia dramatically reduced pH by approximately 0.3 pH units in tumor tissue. Our limited studies on hyperglycemia and hypercapnia are in agreement with the previously published studies and demonstrate the capability of fluorescence ratio imaging microscopy to measure spatial as well as temporal changes in interstitial pH. Fluorescence ratio imaging microscopy should permit noninvasive evaluation of new pH-modifying agents and offer unique mechanistic information about tumor pathophysiology in tissue preparations where the surface of the tissue can be observed.
1 Supported by NIH Grant R35-CA-56591.
2 To whom requests for reprints should be addressed, at Massachusetts General Hospital, Department of Radiation Oncology, Harvard Medical School, Boston, MA 02114.
Received 2/16/94. Accepted 8/31/94.
This article has been cited by other articles:
|
|
 |
|
  A. Makovitzki, A. Fink, and Y. Shai Suppression of Human Solid Tumor Growth in Mice by Intratumor and Systemic Inoculation of Histidine-Rich and pH-Dependent Host Defense-like Lytic Peptides Cancer Res., April 15, 2009; 69(8): 3458 - 3463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Silva, J. A. Yunes, R. J. Gillies, and R. A. Gatenby The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion Cancer Res., March 15, 2009; 69(6): 2677 - 2684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Arnett Extracellular pH Regulates Bone Cell Function J. Nutr., February 1, 2008; 138(2): 415S - 418S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Khalkhali-Ellis and M. J.C. Hendrix Elucidating the Function of Secreted Maspin: Inhibiting Cathepsin D-Mediated Matrix Degradation Cancer Res., April 15, 2007; 67(8): 3535 - 3539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Gerweck, S. Vijayappa, and S. Kozin Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics Mol. Cancer Ther., May 1, 2006; 5(5): 1275 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Komarova, A. Pereverzev, J. W. Shum, S. M. Sims, and S. J. Dixon Convergent signaling by acidosis and receptor activator of NF-{kappa}B ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts PNAS, February 15, 2005; 102(7): 2643 - 2648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Y. W. Bourguignon, P. A. Singleton, F. Diedrich, R. Stern, and E. Gilad CD44 Interaction with Na+-H+ Exchanger (NHE1) Creates Acidic Microenvironments Leading to Hyaluronidase-2 and Cathepsin B Activation and Breast Tumor Cell Invasion J. Biol. Chem., June 25, 2004; 279(26): 26991 - 27007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Gatenby and E. T. Gawlinski The Glycolytic Phenotype in Carcinogenesis and Tumor Invasion: Insights through Mathematical Models Cancer Res., July 15, 2003; 63(14): 3847 - 3854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Karashima, P. Sweeney, A. Kamat, S. Huang, S. J. Kim, M. Bar-Eli, D. J. McConkey, and C. P. N. Dinney Nuclear Factor-{kappa}B Mediates Angiogenesis and Metastasis of Human Bladder Cancer through the Regulation of Interleukin-8 Clin. Cancer Res., July 1, 2003; 9(7): 2786 - 2797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Tanaka, S Chu, M Hirokawa, M H Montrose, and J D Kaunitz Direct measurement of acid permeation into rat oesophagus Gut, June 1, 2003; 52(6): 775 - 783. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Marchetti, E. Caliot, and E. Pringault Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes J. Cell Sci., April 15, 2003; 116(8): 1429 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Helmlinger, A. Sckell, M. Dellian, N. S. Forbes, and R. K. Jain Acid Production in Glycolysis-impaired Tumors Provides New Insights into Tumor Metabolism Clin. Cancer Res., April 1, 2002; 8(4): 1284 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Kuszyk, F. M. Corl, F. N. Franano, D. A. Bluemke, L. V. Hofmann, B. J. Fortman, and E. K. Fishman Tumor Transport Physiology: Implications for Imaging and Imaging-Guided Therapy Am. J. Roentgenol., October 1, 2001; 177(4): 747 - 753. [Full Text] [PDF]
|
|
|
|
|
|
L. Xu and I. J. Fidler Acidic pH-induced Elevation in Interleukin 8 Expression by Human Ovarian Carcinoma Cells Cancer Res., August 1, 2000; 60(16): 4610 - 4616. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Methot, D. W. Silversides, and T. L. Reudelhuber In Vivo Enzymatic Assay Reveals Catalytic Activity of the Human Renin Precursor in Tissues Circ. Res., May 14, 1999; 84(9): 1067 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fitzgerald, M. Omary, and G Triadafilopoulos Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus J. Cell Sci., January 3, 1997; 110(5): 663 - 671. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
